Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,852.81
    -24.24 (-0.31%)
     

  • Bitcoin USD

    64,866.49
    +2,182.04 (+3.48%)
     

  • CMC Crypto 200

    1,334.09
    +21.46 (+1.66%)
     

  • S&P 500

    5,012.95
    +1.83 (+0.04%)
     

  • Dow

    37,975.14
    +199.76 (+0.53%)
     

  • Nasdaq

    15,533.27
    -68.23 (-0.44%)
     

  • Gold

    2,395.80
    -2.20 (-0.09%)
     

  • Crude Oil

    82.75
    +0.02 (+0.02%)
     

  • 10-Yr Bond

    4.6100
    -0.0370 (-0.80%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

AutoZone's (AZO) Q2 Earnings Top, Sales Miss Estimates

Zacks Equity Research
·3-min read

AutoZone, Inc. AZO has reported earnings of $12.39 per share in the second quarter of fiscal 2020 (ended Feb 15, 2020), up from the prior-year quarter figure of $11.49. Further, the reported figure surpassed the Zacks Consensus Estimate of $11.87. Net income inched up 1.6% year over year to $299.3 million.

In the reported quarter, net sales increased 2.6% year over year to $2,513.7 million. However, the top line missed the Zacks Consensus Estimate of $2,580 million.

Domestic commercial sales totaled $556.9 million, up from the $514.6 million recorded in the year-ago quarter. Domestic same-store sales (sales at stores open at least for a year) edged down 0.8% year over year.

Gross profit increased to $1,366 million from the prior-year quarter’s $1,325.1 million. Operating profit also went up to $407.9 million from the $400 million registered in the year-ago period.

ADVERTISEMENT

AutoZone, Inc. Price, Consensus and EPS Surprise

AutoZone, Inc. Price, Consensus and EPS Surprise
AutoZone, Inc. Price, Consensus and EPS Surprise

AutoZone, Inc. price-consensus-eps-surprise-chart | AutoZone, Inc. Quote

Store Opening & Inventory

During the fiscal second quarter, AutoZone opened 25 stores in the United States, two in Mexico and one in Brazil. It exited the quarter with 5,815 stores in the United States, 608 in Mexico and 38 in Brazil. The total store count was 6,461 as of Feb 15, 2020.

AutoZone’s inventory improved 7% year over year in the reported quarter, aided by store openings and increased product placement. At the end of the quarter, inventory per location was $713,000, up from the year-ago figure of $690,000.

Financials and Share Repurchases

AutoZone had cash and cash equivalents of $152.97 million as of Feb 15, 2020, down from $195.66 million as of Feb 9, 2019. Total debt amounted to $5,451.5 million, marking an increase from $5,111.2 million as of Feb 9, 2019.

In the fiscal second quarter, AutoZone repurchased 267,000 shares for $314.8 million at an average price of $1,180 per share. At the end of this period, the company had shares worth $962 million remaining in the current repurchase authorization.

Zacks Rank & Stocks to Consider

AutoZone currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the Auto-Tires-Trucks sector include LCI Industries LCII, SPX Corp. SPXC and Adient PLC ADNT. While LCI sports a Zacks Rank #1 (Strong Buy), SPX and Adient carry a Zacks Rank of 2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

LCI has an estimated earnings growth rate of 20.72% for the ongoing year. The company’s shares have gained 22.7% in a year’s time.

SPX has an expected earnings growth rate of 6.52% for 2020. The stock has rallied 23% in the past year.

Adient has a projected earnings growth rate of 17.79% for the current year. The company’s shares have appreciated 23.4% over the past year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AutoZone, Inc. (AZO) : Free Stock Analysis Report
 
SPX Corporation (SPXC) : Free Stock Analysis Report
 
Adient PLC (ADNT) : Free Stock Analysis Report
 
LCI Industries (LCII) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research